Our Success

We are dedicated to meeting the unmet needs in the healthcare market by developing licensed medicines for patients for whom the administration of current treatments does not meet their requirements.

While new medicines are crucial to address untreated diseases, we prioritise adapting existing molecules into different formulations to improve ease of administration.

Through a blend of patient insight, rigorous data analysis, and dedicated research, we evolve medicines to make them more manageable for patients. Each step of our process is not only what makes us unique, but it contributes to our success and the success of our medicines.

We see the unseen

Our accomplishments are driven by our commitment to actively search for innovative solutions, as we believe that true evolution arises from a combination of data insights and a genuine understanding of patient needs.

By possessing a profound understanding of the disease area and evaluating the landscape we are able to identify opportunities, determining the true necessity and demand for a product that can support unmet needs.

We validate the prospective medicine against clinical understanding, engaging with clinicians, clinical pharmacists, prescribers, patients, and professional groups to outline where and how these potentially fit into current treatment regimes. By combining data-driven insights with our extensive knowledge of the disease area and patient experience, we can uncover unique opportunities others might miss from conventional data analysis.

We manage a
medicine's journey

Our development strategy for each product is individual; our process is thorough and well-defined. Whatever opportunity arises, once we have identified a product that we can reformulate and add value to, we know the steps required to take to create a successful, value-added medicine.

Identification:

We craft a well-structured reformulation proposal that provides a clear and compelling rationale for the project. This includes meticulous market analysis and evaluation to assess the product’s commercial viability and the true clinical need.

Development:

Our team of scientists and reformulation experts design and develop our medicines, ensuring we have all the literature to support the MHRA’s strict regulatory requirements to secure marketing authorisation.

Commercialisation:

After achieving marketing authorisation, our team develops a robust marketing and distribution strategy to introduce the product to healthcare providers and patients, giving them access to alternative medicines and improving health outcomes.

We don't just evolve medicines;
we continue to invest

We turn our developments into commercially successful medicines that can meet the needs of patients whose treatment options may have been limited. With an in-depth understanding of the product’s disease area, we actively seek ways to enhance the tolerability and accessibility of these medicines.

We create more manageable medicines for patients and healthcare professionals, and once we have developed a product, we continue to add value. Through our continued investment in research and development, we extend the life cycles of these medicines and continue to develop them for patient’s evolving needs, allowing further expansion into new markets.

From unmet needs
to global success

Our success is built on identifying an unmet need and developing an appropriate product formulation, along with our ability to commercialise our medicines to reach patients on a global scale.

Our global reach has been achieved through our close collaboration with value-aligned partners. Our in-depth knowledge and expertise of the disease areas, product development, and commercialisation in the UK, complemented by our partners’ deep understanding of their local markets and expertise in their respective fields, empowers us to contribute to our collective success. 

We diligently identify key opinion leaders, professional bodies, and patient advocacy groups who share our mission. Our goal is to provide the necessary tools and insights, enabling them to drive discussions and bridge information gaps in their markets.  Our success hinges on engaging with these groups, listening to their needs, grasping market dynamics, and empowering them through medical education.

We're focused on the future

We are proud to have established ourselves as renowned leaders in repurposing medicines.

As a company, we remain dedicated to innovation, continued investment, and expanding access to treatments for healthcare professionals and patients globally who are facing unmet needs.

Want to be part of our continued success?
We'd love to hear from you

You are now leaving

You are now leaving the Colonis website and being redirected to a Clinigen Group website.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the Clinigen website.

You are now leaving

You are now leaving the Colonis website and being redirected to a Clinigen Group website.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the Clinigen website.

You are now leaving

You are now leaving the Colonis website and being redirected to a Clinigen Group website.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the Clinigen website.

You are now leaving

You are now leaving the Colonis website and being directed to an external website for which Colonis is not responsible.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the external website.

You are now leaving

You are now leaving the Colonis website and being directed to an external website for which Colonis is not responsible.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the external website.